FDA Adverse Event Injury Summary report: N

MECTACER BIOLOX DELTA FEMORAL BALL HEAD

MDR report key: 22911273 · Received August 28, 2025

Report

Report Number
3005180920-2025-00780
Event Type
Injury
Date Received
August 28, 2025
Date of Event
August 1, 2025
Report Date
August 25, 2025
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
LZO
UDI-DI
07630030809187
PMA / PMN Number
K112115
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

BATCH REVIEW PERFORMED ON 04-08-2025. BALL HEADS: MECTACER 01.29.207 MECTACER HEAD BIOLOX DELTA DIA.32 12/14-XL (K112115) LOT 2100267: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 04-03-2021 EXPIRATION DATE: 2026-04-19. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. LINER: MPACT 01.32.3239HCT FLAT PE HC LINER Ø32/C (K103721) LOT. 2215495: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 02-06-2022 EXPIRATION DATE: 2027-08-02. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. ROOT CAUSE: BASED ON THE INFORMATION AVAILABLE NO DEFINITIVE ROOT CAUSE CAN BE ESTABLISHED, WHILE THERE IS NO INDICATION THAT ANY POTENTIAL ISSUE WITH THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT, AND THE DEVICE HISTORY RECORD REVIEW DOES NOT INDICATE ANY POTENTIAL MANUFACTURING RELATED ISSUE.

Description of Event or Problem · 0

AT ABOUT 2 YEARS AND 3 MONTHS FROM PRIMARY, THE PATIENT CAME IN DUE TO PAIN THAT THE SURGEON DETERMINED WAS DUE TO A DISLOCATION WITH THE CAUSE UNKNOWN. THE SURGEON REVISED THE HEAD AND LINER AND THE SURGERY WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1834105 MECTACER BIOLOX DELTA FEMORAL BALL HEAD MECTACER HEAD BIOLOX DELTA DIA.32 12/14-XL LZO MEDACTA INTERNATIONAL SA 01.29.207 2100267 07630030809187

Patients

Seq Age Sex Outcome Treatment
1 NA Female Required Intervention